Your browser doesn't support javascript.
loading
Feasibility and utility of a panel testing for 114 cancer-associated genes in a clinical setting: A hospital-based study.
Sunami, Kuniko; Ichikawa, Hitoshi; Kubo, Takashi; Kato, Mamoru; Fujiwara, Yutaka; Shimomura, Akihiko; Koyama, Takafumi; Kakishima, Hiroki; Kitami, Mayuko; Matsushita, Hiromichi; Furukawa, Eisaku; Narushima, Daichi; Nagai, Momoko; Taniguchi, Hirokazu; Motoi, Noriko; Sekine, Shigeki; Maeshima, Akiko; Mori, Taisuke; Watanabe, Reiko; Yoshida, Masayuki; Yoshida, Akihiko; Yoshida, Hiroshi; Satomi, Kaishi; Sukeda, Aoi; Hashimoto, Taiki; Shimizu, Toshio; Iwasa, Satoru; Yonemori, Kan; Kato, Ken; Morizane, Chigusa; Ogawa, Chitose; Tanabe, Noriko; Sugano, Kokichi; Hiraoka, Nobuyoshi; Tamura, Kenji; Yoshida, Teruhiko; Fujiwara, Yasuhiro; Ochiai, Atsushi; Yamamoto, Noboru; Kohno, Takashi.
Affiliation
  • Sunami K; Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan.
  • Ichikawa H; Department of Clinical Genomics, National Cancer Center Research Institute, Tokyo, Japan.
  • Kubo T; Division of Translational Genomics, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Tokyo, Japan.
  • Kato M; Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan.
  • Fujiwara Y; Department of Clinical Genomics, National Cancer Center Research Institute, Tokyo, Japan.
  • Shimomura A; Division of Translational Genomics, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Tokyo, Japan.
  • Koyama T; Department of Bioinformatics, National Cancer Center Research Institute, Tokyo, Japan.
  • Kakishima H; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan.
  • Kitami M; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan.
  • Matsushita H; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan.
  • Furukawa E; Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan.
  • Narushima D; Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan.
  • Nagai M; Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan.
  • Taniguchi H; Department of Bioinformatics, National Cancer Center Research Institute, Tokyo, Japan.
  • Motoi N; Department of Bioinformatics, National Cancer Center Research Institute, Tokyo, Japan.
  • Sekine S; Department of Bioinformatics, National Cancer Center Research Institute, Tokyo, Japan.
  • Maeshima A; Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan.
  • Mori T; Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan.
  • Watanabe R; Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan.
  • Yoshida M; Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan.
  • Yoshida A; Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan.
  • Yoshida H; Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan.
  • Satomi K; Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan.
  • Sukeda A; Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan.
  • Hashimoto T; Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan.
  • Shimizu T; Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan.
  • Iwasa S; Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan.
  • Yonemori K; Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan.
  • Kato K; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan.
  • Morizane C; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan.
  • Ogawa C; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan.
  • Tanabe N; Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Sugano K; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Hiraoka N; Department of Pediatric Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Tamura K; Genetic Medicine and Services, National Cancer Center Hospital, Tokyo, Japan.
  • Yoshida T; Genetic Medicine and Services, National Cancer Center Hospital, Tokyo, Japan.
  • Fujiwara Y; Oncogene Research Unit/Cancer Prevention Unit, Tochigi Cancer Center Research Institute, Tochigi, Japan.
  • Ochiai A; Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan.
  • Yamamoto N; Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Kohno T; Genetic Medicine and Services, National Cancer Center Hospital, Tokyo, Japan.
Cancer Sci ; 110(4): 1480-1490, 2019 Apr.
Article in En | MEDLINE | ID: mdl-30742731
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biomarkers, Tumor / Gene Expression Profiling / Genes, Neoplasm / Neoplasms Type of study: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Cancer Sci Year: 2019 Document type: Article Affiliation country: Japan Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biomarkers, Tumor / Gene Expression Profiling / Genes, Neoplasm / Neoplasms Type of study: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Cancer Sci Year: 2019 Document type: Article Affiliation country: Japan Country of publication: United kingdom